RxSight, Inc.
RXST
$6.26
-$0.23-3.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.15M | -9.82M | -11.79M | -8.19M | -5.94M |
| Total Depreciation and Amortization | 851.00K | 854.00K | 776.00K | 785.00K | 474.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.60M | 6.03M | 7.65M | 4.78M | 4.73M |
| Change in Net Operating Assets | 584.00K | 1.75M | -1.01M | -6.21M | -3.52M |
| Cash from Operations | -1.12M | -1.19M | -4.38M | -8.83M | -4.26M |
| Capital Expenditure | -1.14M | -581.00K | -1.54M | -575.00K | -847.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.48M | -8.42M | 16.19M | 21.43M | 2.17M |
| Cash from Investing | -9.61M | -9.00M | 14.65M | 20.86M | 1.32M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 9.00K | -19.00K | -3.00K | -13.00K | -12.00K |
| Issuance of Common Stock | 1.06M | 131.00K | 2.07M | 696.00K | 2.99M |
| Repurchase of Common Stock | -2.00K | -642.00K | 0.00 | -1.42M | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 1.06M | -530.00K | 2.07M | -735.00K | 2.98M |
| Foreign Exchange rate Adjustments | -15.00K | -2.00K | 14.00K | 6.00K | -12.00K |
| Miscellaneous Cash Flow Adjustments | -1.00K | -- | -- | -- | -- |
| Net Change in Cash | -9.68M | -10.72M | 12.36M | 11.29M | 24.00K |